Pfizer and BioNTech to seek FDA authorization for first coronavirus vaccine Friday

Pfizer and BioNTech will apply for emergency use authorization for their COVID-19 vaccine from the Food and Drug Administration Friday, making it the first coronavirus vaccine to be considered for widespread use.

“Pfizer’s partner BioNTech has announced that tomorrow, they intend to file for emergency use authorization at the FDA,” Health and Human Services Secretary Alex Azar said Thursday.

Pfizer announced on Nov. 9 that its vaccine candidate had an efficacy as high as 95%, putting it at about the same level of effectiveness as the measles vaccine, at around 97%.

Earlier
Read more…

Please follow and like us: